Manufacturer
Pfizer NDC Codes
Finished products listed with the FDA under labeler names that contain “Pfizer”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Caduetamlodipine and atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-6565 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-6747 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-7232 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-7476 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-7654 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-7810 |
| Celontinmethsuximide | Methsuximide 300 mg/1 | CapsuleOral | Parke-Davis Div of Pfizer Inc | 0071-0525 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-5471 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-5474 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-6001 |
| Chantixvarenicline tartrate | Varenicline tartrate .5 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0468 |
| Chantixvarenicline tartrate | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0469 |
| Chantixvarenicline tartrate | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0069-0471 |
| Cibinqoabrocitinib | Abrocitinib 50 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0235 |
| Cibinqoabrocitinib | Abrocitinib 100 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0335 |
| Cibinqoabrocitinib | Abrocitinib 200 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0435 |
| Comirnatycovid-19 vaccine, mrna | Bnt162b2 omicron (LP.8.1) .0158 mg/.48mL | Injection, SuspensionIntramuscular | Pfizer Laboratories Div Pfizer Inc | 0069-2501 |
| Comirnatycovid-19 vaccine, mrna | Bnt162b2 omicron (LP.8.1) .042 mg/.418mL | Injection, SuspensionIntramuscular | Pfizer Laboratories Div Pfizer Inc | 0069-2528 |
| Comirnatycovid-19 vaccine, mrna | Bnt-162b2 omicron (Xfg) mrna .0158 mg/.48mL | Injection, SuspensionIntramuscular | Pfizer Laboratories Div Pfizer Inc | 0069-2609 |
| Comirnatycovid-19 vaccine, mrna | Bnt-162b2 omicron (Xfg) mrna .042 mg/.418mL | Injection, SuspensionIntramuscular | Pfizer Laboratories Div Pfizer Inc | 0069-2631 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1061 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1476 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1509 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1802 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1960 |